Advertisement

Dietary Management of NIDDM

  • Frank Q. Nuttall
  • Mary C. Gannon
Chapter
Part of the Contemporary Biomedicine book series (CB, volume 15)

Abstract

Noninsulin-dependent diabetes mellitus (NIDDM)* is a heterogenous disease that is genetically determined and, in most people, is dependent on aging and/or obesity for its expression. It is characterized frequently by a resistance to the metabolic effects of insulin (1,2) and always by a relatively impaired insulin secretory response to a high ambient glucose concentration both in the overnight fasting state and after oral or iv administration of glucose (3,4). Whether an impairment in insulin secretion or insulin resistance or both precedes the development of NIDDM is controversial. The contribution of each appears to be highly variable (5).

Keywords

American Diabetes Association Insulin Response Glycemic Index Plasma Glucose Concentration Glucagon Secretion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Himsworth HE The symptoms of diabetes mellitus and its causes. Lancet 1949; 1: 465–472.PubMedCrossRefGoogle Scholar
  2. 2.
    Yalow RS, Berson SA. Immunoassay of endogenous plasma insulin in man. J Clin Invest 1960; 39: 1157–1175.PubMedCrossRefGoogle Scholar
  3. 3.
    Yki-Jävinen H. Pathogenesis of non-insulin-dependent diabetes mellitus. Lancet 1994; 343: 91–95.CrossRefGoogle Scholar
  4. 4.
    Groop LC, Widén E, Ferrannini E. Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: errors of metabolism or of methods? Diabetologia 1993; 36: 1326–1331.PubMedCrossRefGoogle Scholar
  5. 5.
    Chen K-W, Boyko EJ, Bergstrom RW, Leonetti DL, Newell-Morris L, Wahl PW, Fukimoto WY. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. Diabetes Care 1995; 18: 747–753.PubMedCrossRefGoogle Scholar
  6. 6.
    Bouchard C. Genetics and the metabolic syndrome. Int J Obes 1995; 19: S52–S59.Google Scholar
  7. 7.
    Björntorp P. Abdominal obesity and the metabolic syndrome. Ann Med 1992; 24: 465–468.PubMedCrossRefGoogle Scholar
  8. 8.
    Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–1607.PubMedCrossRefGoogle Scholar
  9. 9.
    Osborne RH, DeGeorge FV. Genetic Basis of Morphologic Variation. Harvard University Press, Cambridge, 1959.CrossRefGoogle Scholar
  10. 10.
    Harris MI. Non-insulin-dependent diabetes mellitus in black and white Americans. Metabol Rev 1990; 6: 71–90.CrossRefGoogle Scholar
  11. 11.
    Knowler WC, Pettitt DJ, Saad MF, Bennett PH. Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogensis. Metab Rev 1990; 6: 1–27.CrossRefGoogle Scholar
  12. 12.
    Wingard DL, Barrett-Connor EL, Ferrara A. Is insulin really a heart disease risk factor? Diabetes Care 1995; 18: 1299–1304.PubMedGoogle Scholar
  13. 13.
    Laakso M, Rönnemaa T, Lehto S, Puukka P, Kallio V, Pyörälä K. Does NIDDM increase the risk for coronary heart disease similarly in both low-and high-risk populations? Diabetologia 1995; 38: 487–493.PubMedCrossRefGoogle Scholar
  14. 14.
    Perkins JR, West TET, Sönksen PH, Lowrey C, Iles C. The effects of energy and carbohydrate restriction in patients with chronic diabetes mellitus. Diabetologia 1977; 13: 607–614.PubMedCrossRefGoogle Scholar
  15. 15.
    Wing RR, Blair E, Marcus M, Epstein LH, Harvey J. Year-long weight loss treatment for obese patients with type II diabetes: Does including an intermittent very-low calorie diet improve outcome ? Am J Med 1994; 97: 354–362.PubMedCrossRefGoogle Scholar
  16. 16.
    Laakso M, Uusitupa M, Takala J, Majander H, Reijonen T, Penttila I. Effects of hypocaloric diet and insulin therapy on metabolic control and mechanisms of hyperglycemia in obese noninsulin-dependent diabetic subjects. Metabolism 1988; 37: 1092–1100.PubMedCrossRefGoogle Scholar
  17. 17.
    Ferner RE, Rawlins MD, Alberti KGMM. Impaired (3-cell responses improved when fasting blood glucose concentration is reduced in non-insulin dependent diabetes. Q J Med 1988; 66: 137–146.PubMedGoogle Scholar
  18. 18.
    Vague P, Moulin JP. The defective glucose sensitivity of the 13-cell in NIDDM: improvement after twenty hours of normoglycemia. Metabolism 1982; 31: 138–142.CrossRefGoogle Scholar
  19. 19.
    Oakley WG, Pyke DA, Taylor K. Clinical Diabetes and Its Biochemical Basis. Blackwell Scientific Publications, Oxford & Edinburg, 1968.Google Scholar
  20. 20.
    Wall JR, Pyke DA, Oakley WG. Effect of carbohydrate restriction in obese diabetics: relationship of control to weight loss. Brit Med J 1973; 1: 577–578.PubMedCrossRefGoogle Scholar
  21. 21.
    Gannon MC, Nuttall FQ, Lane JT, Fang S, Gupta V, Sandhofer CR. Effect of twenty-four hours of starvation on plasma glucose and insulin concentrations in people with untreated non-insulin dependent diabetes mellitus. Metabolism, 1996; 45: 492–497.PubMedCrossRefGoogle Scholar
  22. 22.
    Féry F. Role of hepatic glucose production and glucose uptake in the pathogenesis of fasting hyperglycemia in type 2 diabetes:normalization of glucose kinetics by short-term fasting. J Clin Endocrinol Metab 1994; 78: 536–542.PubMedCrossRefGoogle Scholar
  23. 23.
    Gannon MC, Nuttall FQ, Westphal SA, Seaquist ER. The effect of fat with carbohydrate on plasma glucose, insulin, C-peptide and triglycerides in normal male subjects. J Am Coll Nutr 1993; 12: 36–41.PubMedGoogle Scholar
  24. 24.
    Bowen HF, Moorhouse JA. Glucose turnover and disposal in maturity-onset diabetes. J Clin Invest 1973; 52: 3033–3045.PubMedCrossRefGoogle Scholar
  25. 25.
    Kreitzman SN, Coxon AY, Szaz KF. Glycogen storage: illusions of easy weight loss, excessive weight re-gain, and distortions in estimates of body composition. Am J Clin Nutr 1992; 56: 292S–293S.PubMedGoogle Scholar
  26. 26.
    Hughes TA, Gwynne JT, Switzer BR, Herbst C, White G. Effects of caloric restriction and weight loss on glycemic control, insulin release and resistance, and atherosclerotic risk in obese patients with Type II diabetes mellitus. Am J Med 1984; 77: 7–17.PubMedCrossRefGoogle Scholar
  27. 27.
    Uusitupa MiJ, Laakso M, Sarlund H, Majander H, Takala J, Penttilä. Effects of a very-low calorie diet on metabolic control and cardiovascular risk factors in the treatment of obese non-insulin dependent diabetics. Am J Clin Nutr 1990; 51: 768–773.Google Scholar
  28. 28.
    Henry RR, Scheaffer L, Olefsky JM. Glycemic effects of intensive caloric restriction and isocaloric refeeding in non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1985; 61: 917–925.PubMedCrossRefGoogle Scholar
  29. 29.
    Nagulesparan M, Savage PJ, Bennion LJ, Unger RH, Bennett PH. Diminished effect of caloric restriction on control of hyperglycemia with increasing known duration of Type II diabetes mellitus. J Clin Endocrinol Metab 1981; 53: 560–568.PubMedCrossRefGoogle Scholar
  30. 30.
    Henry RR, Wiest-Kent TA, Scheaffer L, Kolterman OG, Olefsky JM. Metabolic consequences of very-low-calorie diet therapy in obese non-insulin-dependent diabetic and non-diabetic subjects. Diabetes Spect 1985; 1: 21–30.Google Scholar
  31. 31.
    Wing RR, Marcus MD, Salata R, Epstein LH, Miaskiewicz S, Blair EH. Effects of a very-lowcalorie diet on long-term glycemic control in obese type 2 diabetic subjects. Arch Intern Med 1991; 151: 1334–1340.PubMedCrossRefGoogle Scholar
  32. 32.
    Newburgh LH. Control of hyperglycemia of obese “diabetics” by weight reduction. Ann Intern Med 1942; 17: 935–942.Google Scholar
  33. 33.
    Savage PT, Bennion LJ, Bennett PH. Normalization of insulin and glucagon secretion in ketosis-resistant diabetes mellitus with prolonged diet therapy. J Endocrinol Metab 1979; 49: 830–833.CrossRefGoogle Scholar
  34. 34.
    Nuttall FQ. Diet and the diabetic patient. Diabetes Care 1983; 6: 197–207.PubMedCrossRefGoogle Scholar
  35. 35.
    Masuzaki H, Ogawa Y, Isse N, Satoh N, Okazaki T, Shigemoto M, Mori K, Tamura N, Hosoda K, Yoshimasa Y, Jingami H, Kawada T, Nakao K. Human obese gene expression. Adipocytespecific expression and regional differences in the adipose tissue. Diabetes 1995; 44: 855–858.PubMedCrossRefGoogle Scholar
  36. 36.
    ADA. Nutritional recommendations and principles for individuals with diabetes mellitus: 1987. Diabetes Care 1987; 10: 126–132.Google Scholar
  37. 37.
    Chait A, Brunzell JD, Denke MA, Eisenberg D, Ernst ND, Franklin FAJ, Ginsberg H, Kotchen TA, Kuller L, Mullis RM, Nichaman MZ, Nicolosi RJ, Schaefer EJ, Stone NJ, Weidman WH. Rationale of the diet-heart statement of the American Health Association. Report of the Nutrition Committee. Circulation 1993; 88: 3008–3029.PubMedCrossRefGoogle Scholar
  38. 38.
    Nuttall FQ. Dietary fiber in the management of diabetes. Diabetes. 1993; 42: 503–508.PubMedCrossRefGoogle Scholar
  39. 39.
    Vinik AI, Lauterio TJ, Wing RR. Should the bee suck honey or lard? Diabetes Care 1993; 16: 1045–1047.PubMedCrossRefGoogle Scholar
  40. 40.
    Garg A, Bantle JP, Henry RR, Colston AM, Griver KA, Raatz SK, Brinkley L, Chen Y-D, Grundy SM, Huet BA, Reaven GM. Effects of varying carbohydrate content of diet in patients with non-insulin dependent diabetes mellitus. JAMA 1994; 271: 1421–1428.PubMedCrossRefGoogle Scholar
  41. 41.
    Cominacini L, Zocca I, Garbin U, Davoli A, Compri R, Brunetti L, Bosello O. Long-term effect of a low-fat, high-carbohydrate diet on plasma lipids of patients affects by familial endogenous hypertriglyceridemia. Am J Clin Nutr 1988; 48: 57–65.PubMedGoogle Scholar
  42. 42.
    Garg A. High-monounsaturated fat diet for diabetic patients. Diabetes Care 1994; 17: 242–246.PubMedCrossRefGoogle Scholar
  43. 43.
    Hegsted DM. Dietary fatty acids, serum cholesterol and coronary heart disease. In: Health Effects of Dietary Fatty Acids, Nelson GJ, ed. Champaign, IL: American Oil Chemists Society, 50–68, 1991.Google Scholar
  44. 44.
    Westerterp KR. Food quotients, respiratory quotient, and energy balance. Am J Clin Nutr 1993; 57: 759S–765S.PubMedGoogle Scholar
  45. 45.
    Acheson KJ, Schutz Y, Bessard T, Anantharaman K, Flatt J-P, Jéquier E. Glycogen storage capacity and de novo lipogenesis during massive carbohydrate overfeeding in man. Am J Clin Nutr 1988; 48: 240–247.PubMedGoogle Scholar
  46. 46.
    Boozer CN, Schoenbach G, Atkinson RL. Dietary fat and adiposity: a dose-response relationship in adult male rats fed isocalorically. Am J Physiol 1995; 268: E546–E550.PubMedGoogle Scholar
  47. 47.
    Carroll KK. Dietary fats and cancer. Am J Clin Nutr 1991; 53: 1064S–1067S.PubMedGoogle Scholar
  48. 48.
    Hollenbeck CB. Dietary fructose effects on lipoprotein metabolism and risk for coronary artery disease. Am J Clin Nutr 1993; 58: 800S–809S.PubMedGoogle Scholar
  49. 49.
    Coulston AM, Hollenbeck CB, Swislocki ALM, Chen Y-D, Reaven GM. Deleterious metabolic effects of high-carbohydrate, sucrose-containing diets in patients with non-insulin dependent diabetes mellitus. Am J Med 1987; 82: 213–220.PubMedCrossRefGoogle Scholar
  50. 50.
    Hjermann I, Velve Byre K, Holme I, Leren P. Effect of diet and smoking intervention on the incidence of coronary heart disease: report from the Oslo Study Group of a randomized trial in health men. Lancet 1981; 2: 1303–1310.PubMedCrossRefGoogle Scholar
  51. 51.
    O’Dea K, Traianedes K, Ireland P, Niall M, Sadler J, Hopper J, De Luise M. The effects of diet differing in fat, carbohydrate, and fiber on carbohydrate and lipid metabolism in type II diabetes. J Am Diet Assoc 1989; 89: 1076–1086.PubMedGoogle Scholar
  52. 52.
    Cummings MH, Watts GF, Umpleby AM, Hennessy TR, Naoumova R, Slavin BM, Thompson GR. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM. Diabetologia 1995; 38: 959–967.PubMedCrossRefGoogle Scholar
  53. 53.
    Lewis GF, Uffelman KD, Steiner SLW and Steiner G. Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals. Diabetes 1993; 42: 833–842.PubMedCrossRefGoogle Scholar
  54. 54.
    Mayes PA. Intermediary metabolism of fructose. Am J Clin Nutr 1993; 58: 754S–765S.PubMedGoogle Scholar
  55. 55.
    Bantle JP, Swanson JE, Thomas W, Laine DC. Metabolic effects of dietary fructose in diabetic subjects. Diabetes Care 1992; 15: 1468–1476.PubMedCrossRefGoogle Scholar
  56. 56.
    Kaufmann NA, Poznanski R, Blondheim H, Stein Y. Comparison of effects of fructose, sucrose, glucose and starch on serum lipids in patients with hypertriglyceridemia and normal subjects. Am J Clin Nutr 1967; 20: 131–132.PubMedGoogle Scholar
  57. 57.
    Hill P. Effect of fructose on rat lipids. Lipids 1970; 5: 621–627.PubMedCrossRefGoogle Scholar
  58. 58.
    Nikkila EA, Ojala K. Induction of hyperglyceridemia by fructose in the rat. Life Sci 1965; 4: 937–943.PubMedCrossRefGoogle Scholar
  59. 59.
    Martinez FJ, Rizza RA, Romero JC. High-fructose feeding elicits insulin resistance, hyperinsulinism, and hypertension in normal mongrel dogs. Hypertension 1994; 23: 456–463.PubMedCrossRefGoogle Scholar
  60. 60.
    Hill R, Chaikoff IL. Loss and repair of glucose-disposal mechanism in dog fed fructose as sole dietary carbohydrate. Proc Soc Exp Biol Med 1956; 91: 265–267.PubMedGoogle Scholar
  61. 61.
    Osei K, Falko J, Bossetti BM, Holland GC. Metabolic effects of fructose as a natural sweetener in the physiologic meals of ambulatory obese patients with type II diabetes. Am J Med 1987; 83: 249–255.PubMedCrossRefGoogle Scholar
  62. 62.
    Osei K, Bossetti B. Dietary fructose as a natural sweetener in poorly controlled type 2 diabetes: a 12-month crossover study of effects on glucose, lipoprotein and apolipoprotein metabolism. Diabetes Med 1989; 6: 506–511.CrossRefGoogle Scholar
  63. 63.
    Thorburn AW, Crapo PA, Beltz WF, Wallace P, Witztum JL, Henry RR. Lipid metabolism in non-insulin-dependent diabetes: effects of long-term treatment with fructose-supplemented mixed meals. Am J Clin Nutr 1989; 50: 1015–1022.PubMedGoogle Scholar
  64. 64.
    Abraira C, Derler J. Large variations of sucrose in constant carbohydrate diets in type II diabetes. Am J Med 1988; 84: 193–200.PubMedCrossRefGoogle Scholar
  65. 65.
    Glinsmann WH, Park YK. Perspective on the 1986 Food and Drug Administration assessment of the safety of carbohydrate sweeteners: uniform definitions and recommendations for future assessments. Am J Clin Nutr 1995; 62: 161S–169S.PubMedGoogle Scholar
  66. 66.
    Nuttall FQ, Gannon MC, Burmeister LA, Lane JT, Pyzdrowski KL. The metabolic response to various doses of fructose in type II diabetic subjects. Metabolism 1992; 41: 510–517.PubMedCrossRefGoogle Scholar
  67. 67.
    Reiser S, Hallfrisch J, Michaelis VI, Lazar FL, Martin RE, Prather ES. Isocaloric exchange of dietary starch and sucrose in humans. I. Effects on levels of fasting blood lipids. Am J Clin Nutr 1979; 32: 1659–1669.PubMedGoogle Scholar
  68. 68.
    Jeppesen J, Chen Y-D, Zhou M-Y, Schaaf P, Coulston A, Reaven GM. Postprandial triglyceride and retinyl ester responses to oral fat: effects of fructose. Am J Clin Nutr 1995; 61: 787–791.PubMedGoogle Scholar
  69. 69.
    Hirano T, Mamo JCL, Poapst ME, Kuksis A, Steiner G. Impaired very low-density lipoproteintriglyceride catabolism in acute and chronic fructose-fed rats. Am J Physiol 1989; 256: E559–E565.PubMedGoogle Scholar
  70. 70.
    Grant KI, Marais MP, Dhansay MA. Sucrose in a lipid-rich meal amplifies the postprandial excursion of serum and lipoprotein triglyceride and cholesterol concentrations by decreasing triglyceride clearance. Am J Clin Nutr 1994; 59: 853–860.PubMedGoogle Scholar
  71. 71.
    Georgopoulos A, Bantle JP. Is high monounsaturated fat (mono) diet “bad” for patients with insulin-dependent diabetes mellitus (IDDM)? Diabetes 1994; 43: 37A (abstract 112).Google Scholar
  72. 72.
    Gerrits PM, Tsalikian. Diabetes and fructose metabolism. Am J Clin Nutr 1993; 58: 796S–799S.PubMedGoogle Scholar
  73. 73.
    Langer RD, Criqui MH, Reed DM. Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease. Circulation 1992; 85: 910–915.PubMedCrossRefGoogle Scholar
  74. 74.
    Pirwitz MJ, Lange RA, Willard JE, Landau C, Glamann DB, Foerster EH, Todd E, Hillis LD. Effects of intravenous ethanol on diameter of epicardial coronary arteries. Am J Cardiol 1995; 75: 77–91.PubMedCrossRefGoogle Scholar
  75. 75.
    Randin D, Vollenweider P, Tappy L, Jéquier E, Nicod P, Scherrer U. Suppression of alcohol-induced hypertension by dexamethasone. New Engl J Med 1995; 332: 1733–1737.PubMedCrossRefGoogle Scholar
  76. 76.
    LaPorte RE, Brenes G, Dearwater S, Murphy MA, Cauley JA, Dietrick R, Robertson R. HDL cholesterol across a spectrum of physical activity from quadriplegia to marathon running. Lancet 1983; 1: 1212–1213.PubMedCrossRefGoogle Scholar
  77. 77.
    Horton ES. Role and management of exercise of diabetes mellitus. Diabetes Care 1988; 11: 201–211.PubMedCrossRefGoogle Scholar
  78. 78.
    Mooradian AD, Nuttall FQ. Insulin sensitivity in joggers: evaluation by mini-dose insulin infusion test. Int J Sports Med 1985; 6: 212–214.PubMedCrossRefGoogle Scholar
  79. 79.
    Helmrich SP, Ragland DR, Leung RW, Paffenbarger RSJ. Physical activity and reduced occurrence of non-insulin dependent diabetes mellitus. New Engl J Med 1991; 325: 147–152.PubMedCrossRefGoogle Scholar
  80. 80.
    Himsworth AP. High carbohydrate diets and insulin efficiency. Br Med J 1934; 2: 57–60.PubMedCrossRefGoogle Scholar
  81. 81.
    Nuttall FQ, Gannon MC, Wald JL, Ahmed M. Plasma glucose and insulin profiles in normal subjects ingesting diets of varying carbohydrate, fat and protein content. J Am Coll Nutr 1985; 4: 437–450.PubMedGoogle Scholar
  82. 82.
    Kolterman O, Greenfield M, Reaven G. Effect of a high carbohydrate diet on insulin binding to adipocytes and on insulin action in-vivo in man. Diabetes 1979; 28: 731–736.PubMedCrossRefGoogle Scholar
  83. 83.
    Brunzell JD, Lerner RL, Hazzard WR. Improved glucose tolerance with high carbohydrate feeding in mild diabetes. New Engl J Med 1974; 284: 521–524.CrossRefGoogle Scholar
  84. 84.
    Ireland P, O’Dea K, Nankervis A. Short-term effects of alterations in dietary fat on metabolic control in IDDM. Diabetes Care 1992; 15: 1499–1504.PubMedCrossRefGoogle Scholar
  85. 85.
    Nuttall FQ. The high-carbohydrate diet in diabetes management. Adv Intern Med 1988; 33: 165–184.PubMedGoogle Scholar
  86. 86.
    Garg A, Grundy SM, Koffler M. Effect of high carbohydrate intake on hyperglycemia, islet function, and plasma lipoproteins in NIDDM. Diabetes Care 1992; 15: 1572–1580.PubMedCrossRefGoogle Scholar
  87. 87.
    Parillo M, Rivellese AA, Ciardullo AV, Capaldo B, Giacco A, Genovese S, Raccardi G. A highmonounsaturated-fat/low-carbohydrate diet improves peripheral insulin sensitivity in noninsulin-dependent diabetic patients. Metabolism 1992; 41: 1373–1378.PubMedCrossRefGoogle Scholar
  88. 88.
    Stampfer MJ, Malinow MR. Can lowering homocysteine levels reduce cardiovascular risk? New Engl J Med 1995; 332: 328–329.PubMedCrossRefGoogle Scholar
  89. 89.
    Seffhub J, Jackques PF, Bostom AG, D’Agostino RB, Wilson PWF, Belanger AJ, O’Leary DH, Wolf PA, Schaefer EJ, Rosenberg IH. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. New Engl J Med 1995; 332: 286–291.CrossRefGoogle Scholar
  90. 90.
    Ueland PM, Refsum H, Brattström L. Plasma homocysteine and cardiovascular disease. In: Atherosclerotic Cardiovascular Disease, Hemostasis, and Endothelial Function. Francis RB Jr, ed. New York: Marcel Dekker, pp. 183–236, 1992.Google Scholar
  91. 91.
    Goyette P, Summer JS, Milos R, et al. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nature Genet 1994; 7: 195–200.PubMedCrossRefGoogle Scholar
  92. 92.
    Unger RH. Glucagon physiology and pathophysiology. New Engl J Med 1971; 285: 443–449.PubMedCrossRefGoogle Scholar
  93. 93.
    Labbe M. Tolerame Comparee des divers hydrates de carbone Par l’organisme des diabetiques. Bull Mem Soc Med Hop (Paris). 1907; 24: 221–234.Google Scholar
  94. 94.
    MacLean H. Modern Methods in the Diagnosis and Treatment of Glycosuria and Diabetes. London: Constable & Co. Ltd., 1924.Google Scholar
  95. 95.
    Otto H, Bleyer G, Penhartz M, Sabin K, Schaugerger G, Spaethe R. Kohlenhydrataustausch nach biologischen equivalenten. In: Otto H, Spaeth R, eds. Bern: Huber, pp. S41–S51, 1973.Google Scholar
  96. 96.
    Wolever TMS. The glycemic index. World Rev Nutr Diet 1990; 62: 120 - 185.PubMedGoogle Scholar
  97. 97.
    Wolever TMS, Katzman-Relle L, Jenkins AL, Vuksan V, Josse RG, Jenkins DJA. Glycaemic index of 102 complex carbohydrate foods in patients with diabetes. Nutr Res 1994; 14: 651–669.CrossRefGoogle Scholar
  98. 98.
    Gannon MC, Nuttall FQ. Factors affecting interpretation of postprandial glucose and insulin area. Diabetes Care 1987; 10: 759–763.PubMedCrossRefGoogle Scholar
  99. 99.
    Gannon MC, Nuttall FQ, Westphal SA. Effects of dose of ingested glucose on plasma metabolite and hormone responses in type II diabetic subjects. Diabetes Care 1989; 12: 544–552.PubMedCrossRefGoogle Scholar
  100. 100.
    Ercan N, Nuttall FQ, Gannon MC, Redmon JB, Sheridan KJ. Effects of glucose, galactose and lactose on the plasma glucose and insulin response in persons with non-insulin-dependent diabetes mellitus. Metabolism 1993; 42: 1560–1567.PubMedCrossRefGoogle Scholar
  101. 101.
    Würsch R. Starch in human nutrition. World Rev Nutr Diet 1989; 60: 199–256.PubMedGoogle Scholar
  102. 102.
    Rosenthal S, Zeigler E. The effect of uncooked starches on the blood sugar of normal and of diabetic subjects. Arch Intern Med 1929; 44: 344–350.CrossRefGoogle Scholar
  103. 103.
    Nilsson LH, Hultman E. Liver and muscle glycogen in man after glucose and fructose infusion. Scand J Clin Lab Invest 1974; 33: 5–10.PubMedCrossRefGoogle Scholar
  104. 104.
    Tygstrup N, Winkler K. Galactose blood clearance as a measure of hepatic blood flow. Clin Sci 1958; 17: 1–9.PubMedGoogle Scholar
  105. 105.
    Radziuk J, MacDonald TJ, Rubenstein D. Initial splanchnic extraction of ingested glucose in normal man. Metabolism 1978; 27: 657–669.PubMedCrossRefGoogle Scholar
  106. 106.
    Gannon MC, Nuttall FQ. Glucose and insulin responses to meals designed according to American Diabetes Association (ADA) recommendations, typical American diet, or containing simple sugars and dairy foods in subjects with non-insulin dependent diabetes mellitus (NIDDM). JAm Coll Nutr 1993; 12: 611 (abstract 110A).Google Scholar
  107. 107.
    Nuttall FQ, Mooradian AD, DeMarais R. The glycemic effect of different meals approximately isocaloric and similar in protein, carbohydrate and fat content as calculated using the ADA exchange lists. Diabetes Care 1983; 6: 432–435.PubMedCrossRefGoogle Scholar
  108. 108.
    Nuttall FQ, Gannon MC. The quantitative importance of dietary constituents other than carbohydrate or protein as insulin secretagogues in type II diabetes. Diabetes Care 1988; 11: 72–76.PubMedCrossRefGoogle Scholar
  109. 109.
    Fajans SS, Floyd JCJ, Knopf RF, Conn JW. Effect of amino acids and proteins on insulin secretion in man. Recent Prog Horm Res 1967; 23: 617–622.PubMedGoogle Scholar
  110. 110.
    May JM, Williams RH. The effect of endogenous gastric inhibitory polypeptide on glucose-induced insulin secretion in mild diabetes. Diabetes 1978; 27: 849–855.PubMedGoogle Scholar
  111. 111.
    Böttger I, Dobbs R, Faloona GR, Unger RH. The effects of triglyceride absorption upon glucagon, insulin and gut glucagon-like immunoreactivity. J Clin Invest 1973; 52: 25–32.CrossRefGoogle Scholar
  112. 112.
    Khan MA, Gannon MC, Nuttall FQ. Glucose appearance rate following protein ingestion in normal subjects. J Am Coll Nutr 1992; 11: 701–706.PubMedGoogle Scholar
  113. 113.
    Krezowski PA, Nuttall FQ, Gannon MC, Bartosh NH. The effect of protein ingestion on the metabolic response to oral glucose in normal individuals. Am J Clin Nutr 1986; 44: 847–856.PubMedGoogle Scholar
  114. 114.
    Nuttall FQ, Gannon MC. Metabolic response to egg white and cottage cheese protein in normal subjects. Metabolism 1990; 39: 749–755.PubMedCrossRefGoogle Scholar
  115. 115.
    Gannon MC, Nuttall FQ, Lane JT, Burmeister LA. Metabolic response to cottage cheese or egg white protein, with or without glucose in type II diabetic subjects. Metabolism 1992; 41: 1137–1145.PubMedCrossRefGoogle Scholar
  116. 116.
    Fajans SS, Floyd JC, Pek S, Knopf RF, Jacobson M, Conn JW. Effect of protein meals on plasma insulin in mildly diabetic patients. Diabetes 1969; 18: 523–528.PubMedGoogle Scholar
  117. 117.
    Nuttall FQ, Mooradian AD, Gannon MC. Effect of protein ingestion on the glucose and insulin response to a standardized oral glucose load. Diabetes Care 1984; 7: 465–470.PubMedCrossRefGoogle Scholar
  118. 118.
    Gannon MC, Nuttall FQ, Neil BJ. The insulin and glucose responses to meals of glucose plus various proteins in type II diabetic subjects. Metabolism 1988; 37: 1081–1088.PubMedCrossRefGoogle Scholar
  119. 119.
    Westphal SA, Gannon MC, Nuttall FQ. The metabolic response to glucose ingested with various amounts of protein. Am J Clin Nutr 1990; 52: 267–272.PubMedGoogle Scholar
  120. 120.
    Unger R, Orci L. Physiology and pathophysiology of glucagon. Physiol Rev 1976; 56: 778–826.PubMedGoogle Scholar
  121. 121.
    Collier G, O’Dea K. The effect of coingestion of fat on the glucose, insulin, and gastric inhibitory polypeptide responses to carbohydrate and protein. Am J Clin Nutr 1983; 37: 941–944.PubMedGoogle Scholar
  122. 122.
    Gannon MC, Ercan N, Westphal SA, Nuttall FQ. Effect of added fat on the plasma glucose and insulin response to ingested potato in individuals with NIDDM. Diabetes Care 1993; 16: 874–880.PubMedCrossRefGoogle Scholar
  123. 123.
    Ercan N, Gannon MC, Nuttall FQ. Effect of added fat on the plasma glucose and insulin response to ingested potato given in various combinations as two meals in normal individuals. Diabetes Care 1994; 17: 1453–1459.PubMedCrossRefGoogle Scholar
  124. 124.
    Andrews SS, Lopez SA, Blackard WG. Effect of lipids on glucagon secretion in man. Metabolism 1975; 24: 35.PubMedCrossRefGoogle Scholar
  125. 125.
    MacDonald I, Keyser A, Pacy D. Some effects in man of varying the load of glucose, sucrose, fructose or sorbitol on various metabolites in blood. Am J Clin Nutr 1979; 31: 1305–1311.Google Scholar
  126. 126.
    Gannon MC, Nuttall FQ, Krezowski PA. The serum insulin and plasma glucose responses to milk and fruit products in type 2 diabetic subjects. Diabetologia 1986; 29: 784–791.PubMedCrossRefGoogle Scholar
  127. 127.
    Bohannon NV, Karam JH, Fosham PH. Endocrine responses to sugar ingestion in man. J Am Diet Assoc 1980; 76: 555–560.PubMedGoogle Scholar
  128. 128.
    Khan MA, Gannon MC, Nuttall FQ. Hepatic glucose production following ingestion of fructose in men. JAm Coll Nutr 1992; 11: 618 (abstract 71).Google Scholar
  129. 129.
    Crapo PA, Kolterman OG, Olefsky JM. Effects of oral fructose in normal, diabetic, and impaired glucose tolerance subjects. Diabetes Care 1980; 3: 575–581.PubMedCrossRefGoogle Scholar
  130. 130.
    Samols E, Stagner J. Intra-islet regulation. Am J Med 1988; 85: 31–35.PubMedCrossRefGoogle Scholar
  131. 131.
    Williams CA, Phillips T, MacDonald I. The influence of glucose on serum galactose levels in man. Metabolism 1983; 32: 250–256.PubMedCrossRefGoogle Scholar
  132. 132.
    Grodsky GM, Batts AS, Bennett LL, Vcella C, McWillaims NB, Smith DF. Effects of carbohydrates on secretion of insulin from isolated rat pancreas. Am J Physiol 1963; 205: 638–644.PubMedGoogle Scholar
  133. 133.
    Christiansen C, Thomsen C, Rasmussen 0, Glerup H, Bertelsen J, Hansen C, Orskov H, Hermansen K. Acute effects of graded alcohol intake on glucose and insulin levels in noninsulin dependent diabetic (NIDDM) subjects. Eur J Clin Nutr 1993; 47: 648–652.PubMedGoogle Scholar
  134. 134.
    Christiansen C, Thomsen C, Rasmussen 0, Hauerslev C, Balle M, Hansen C, Hermansen K. Effect of alcohol on glucose, insulin, free fatty acid and triacylglycerol responses to a light meal in non-insulin-dependent diabetic subjects. Br J Nutr 1994; 71: 449–454.PubMedCrossRefGoogle Scholar
  135. 135.
    Marks V. Alcohol and carbohydrate metabolism. Clin Endocrinol Metab 1978; 7: 333–349.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Frank Q. Nuttall
  • Mary C. Gannon

There are no affiliations available

Personalised recommendations